Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Morphic Holding, Inc. (MORF)  
$28.62 0.51 (1.75%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,740,000
Market Cap: 1.42(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $19.95 - $62.11
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 7.4
Insider 3/6 Months : 8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Morphic is a biopharmaceutical company. Co. is applying its proprietary insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with various approved injectable blockbuster drugs for the treatment of chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. Co. is developing its pipeline, including its main product candidate, MORF-057, an a4ss7-specific integrin inhibitor affecting inflammation, into clinical development for the treatment of inflammatory bowel disease. Co. has also developed selective oral avss6-specific integrin inhibitors including MORF-720 and MORF-627.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 4,776 4,776 1,054,776
Total Buy Value $0 $98,239 $98,239 $47,348,239
Total People Bought 0 2 2 3
Total Buy Transactions 0 2 2 3
Total Shares Sold 0 35,876 89,165 317,833
Total Sell Value $0 $986,256 $4,041,896 $15,087,539
Total People Sold 0 5 5 5
Total Sell Transactions 0 5 14 29
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 366
  Page 9 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Stampacchia Otello Director   –       •      –    2021-01-25 4 AS $30.88 $205,421 D/D (6,623) 2,794,111 70%     
   Stampacchia Otello Director   –       •      –    2021-01-22 4 AS $30.64 $299,610 D/D (9,741) 2,800,734 74%     
   Stampacchia Otello Director   –       •      –    2021-01-21 4 AS $29.98 $7,915 D/D (264) 2,810,475 77%     
   Stampacchia Otello Director   –       •      –    2021-01-19 4 AS $29.95 $517,888 D/D (17,238) 2,810,739 64%     
   Stampacchia Otello Director   –       •      –    2021-01-15 4 AS $30.49 $435,672 D/D (14,289) 2,827,977 65%     
   Stampacchia Otello Director   –       •      –    2021-01-14 4 AS $30.27 $282,809 D/D (9,241) 2,842,266 51%     
   Stampacchia Otello Director   –       •      –    2021-01-13 4 AS $30.11 $202,941 D/D (6,740) 2,851,507 50%     
   Stampacchia Otello Director   –       •      –    2021-01-12 4 AS $30.10 $173,316 D/D (5,758) 2,858,247 51%     
   Stampacchia Otello Director   –       •      –    2021-01-11 4 AS $30.15 $101,967 D/D (3,382) 2,864,005 53%     
   Stampacchia Otello Director   –       •      –    2021-01-08 4 AS $30.13 $271,984 D/D (9,027) 2,867,387 49%     
   Rogers Bruce Chief Scientific Officer   •       –      –    2021-01-07 4 AS $30.10 $70,999 D/D (2,359) 109,105 57%     
   Stampacchia Otello Director   –       •      –    2021-01-07 4 AS $29.98 $483,907 D/D (16,141) 2,876,414 57%     
   Stampacchia Otello Director   –       •      –    2021-01-06 4 AS $30.09 $361,923 D/D (12,024) 2,892,555 56%     
   Rogers Bruce Chief Scientific Officer   •       –      –    2021-01-06 4 AS $30.15 $339,379 D/D (11,240) 111,464 56%     
   Tipirneni Praveen P. President and CEO   •       •      –    2021-01-05 4 AS $30.94 $49,951 I/I (1,604) 626,474 52%     
   Tipirneni Praveen P. President and CEO   •       •      –    2021-01-05 4 AS $30.96 $51,513 D/D (1,653) 3,813 52%     
   Tipirneni Praveen P. President and CEO   •       •      –    2021-01-05 4 OE $4.32 $7,141 D/D 1,653 5,466     -
   Stampacchia Otello Director   –       •      –    2021-01-05 4 AS $30.89 $414,088 D/D (13,324) 2,904,579 52%     
   Rogers Bruce Chief Scientific Officer   •       –      –    2021-01-05 4 AS $30.86 $446,572 D/D (14,451) 122,704 52%     
   Tipirneni Praveen P. President and CEO   •       •      –    2021-01-04 4 AS $32.54 $78,514 I/I (2,396) 628,078 48%     
   Tipirneni Praveen P. President and CEO   •       •      –    2021-01-04 4 AS $32.52 $76,802 D/D (2,347) 3,813 48%     
   Tipirneni Praveen P. President and CEO   •       •      –    2021-01-04 4 OE $4.32 $10,139 D/D 2,347 6,160     -
   Stampacchia Otello Director   –       •      –    2021-01-04 4 AS $32.57 $396,305 D/D (12,118) 2,917,903 48%     
   Rogers Bruce Chief Scientific Officer   •       –      –    2021-01-04 4 AS $32.51 $390,985 D/D (11,950) 137,155 48%     
   Farrell Robert E Jr SVP Finance and CAO   •       –      –    2020-12-30 4 AS $32.56 $239,781 D/D (7,364) 27,934 43%     
  366 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us